Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL
NCT06938100 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-04-22
Summary
The project aims to retrospectively and prospectively analyze a population of CADASIL patients in order to study the natural history of the disease by correlating the symptom spectrum with genetic risk and specific neuroradiological and biological markers
\- Stratifying patients according to their disease risk, this could contribute to the discovery of personalized therapeutic targets.
Conditions
- CADASIL
- CADASIL (Diagnosis)
Sponsors & Collaborators
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-21
- Primary Completion
- 2027-04-30
- Completion
- 2027-10-31
Countries
- Italy
- Spain
Study Locations
More Related Trials
-
Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
NCT01114815 ·Status: COMPLETED
-
New CSF Biomarkers for Alzheimer's Disease
NCT03621839 ·Status: RECRUITING
-
CADASIL Registry Study
NCT04310098 ·Status: RECRUITING
-
Relationship Between Protein Biomarkers in Cerebrospinal Fluid and Alzheimer&Apos;s Disease in Patients With Depression
NCT02303158 ·Status: TERMINATED
-
Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)
NCT03541226 ·Status: COMPLETED
-
National Database of the Virtual Institute of Cerebrovascular Diseases
NCT05925699 ·Status: NOT_YET_RECRUITING
-
Predictive Value of Biomarkers of the Alzheimer's Disease (AD) in Elderly Patients With New-onset Epilepsy
NCT02861846 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Assessment of Protein Markers in the Cerebrospinal Fluid of Patients With Central Nervous System Involvement
NCT07313098 ·Status: NOT_YET_RECRUITING
-
Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers
NCT06561906 ·Status: RECRUITING
-
Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment
NCT01425957 ·Status: COMPLETED ·Phase: NA
-
Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment
NCT00684281 ·Status: COMPLETED ·Phase: NA
-
Novel Neuroradiological Workflow for the Assisted DIAgnosis and Management of DEMentia with Artificial Intelligence
NCT06877182 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk
NCT07007208 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Predictors of Better Outcomes After Severe Acquired Brain Injuries
NCT04495192 ·Status: UNKNOWN
-
Expanding the Biomarkers in Familial Amyloid Neuropathy: MRI and Motor Unit Estimation by Electrophysiological Study
NCT03588468 ·Status: COMPLETED ·Phase: NA
-
Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.
NCT01876459 ·Status: UNKNOWN ·Phase: NA
-
Computational Medical Imaging and Prediction of Diffusion/FLAIR Mismatch in Stroke Patients
NCT05192161 ·Status: UNKNOWN
-
Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment
NCT06965816 ·Status: COMPLETED
-
Stratification of Presymptomatic Amyotrophic Lateral Sclerosis: the Development of Novel Imaging Biomarkers
NCT05358431 ·Status: RECRUITING ·Phase: NA
-
Cognitive Function and Prevalence of Amyloid Marker in Frail Older Adults
NCT03129269 ·Status: COMPLETED ·Phase: NA
-
Biomarkers and Early Alzheimer's Disease
NCT00094952 ·Status: UNKNOWN
-
Biomarkers for Monitoring Dementia Progression
NCT06855368 ·Status: RECRUITING
-
Neuroimaging Markers of Alzheimer Disease: a Longitudinal Population Study
NCT01582919 ·Status: COMPLETED ·Phase: NA
-
The Fingerprinting of Inherited Leukoencephalopathies: A New Brain Imaging, Genetic and Clinical Assessment
NCT06332625 ·Status: RECRUITING
-
Ccf mtDNA as a Neurodegenerative Biomarker
NCT03938909 ·Status: UNKNOWN